|
 |
ZileutonThis page contains recent news articles, when available, and an overview of Zileuton but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Zileuton (when available) Zileuton is an orally active inhibitor of 5-lipoxygenase, the enzyme that catalyzes the formation of leukotrienes from arachidonic acid. Zileuton is indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older. For the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older Mechanism Of Action: Zileuton is a specific inhibitor of 5-lipoxygenase and thus inhibits leukotriene (LTB4, LTC4, LTD4, and LTE4) formation. Both the R(+) and S(-) enantiomers are pharmacologically active as 5-lipoxygenase inhibitors in in vitro systems. Leukotrienes are substances that induce numerous biological effects including augmentation of neutrophil and eosinophil migration, neutrophil and monocyte aggregation, leukocyte adhesion, increased capillary permeability, and smooth muscle contraction. These effects contribute to inflammation, edema, mucus secretion, and bronchoconstriction in the airways of asthmatic patients. News Articles on Zileuton Critical Therapeutics says FDA OK's partner's product - May 14, 2007 Pacific Growth Equities analyst Greg Wade feels the stock is up on the combined effect of Dey's product approval and expectation that Critical's zileuton CR ... Reuters … ' Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for ... - May 31, 2007 ZYFLO CR and ZYFLO® (zileuton tablets) are the only FDA-approved leukotriene synthesis inhibitors for the prophylaxis and chronic treatment of asthma in ... RedOrbit … Data for Controlled-Release Formulation of Zileuton Presented at... - Nov 15, 2006 The Company submitted its New Drug Application (NDA) for zileuton CR to the US ... Pending regulatory approval, the Company expects to launch zileuton CR in ... Genetic Engineering News - Genetic Engineering News (press release) … Announces Results from Phase II Study of Zileuton in Acne Patients. - Jul 14, 2005 The patients receiving zileuton did show positive responses to treatment and a trend ... In the study, zileuton was found to be safe and well tolerated. ... $4.95 - Business Wire - ECNext … Acceptance of Controlled-Release Zileuton New Drug Application for... - Oct 17, 2006 Zileuton CR is an investigational drug developed for the prevention and chronic treatment of asthma in adults and children 12 years of age and older. ... Genetic Engineering News - Genetic Engineering News (press release) Skyepharma PLC - Agreement for Zileuton CR. - Mar 15, 2007 RNS Number:9870S Skyepharma PLC 15 March 2007 For Immediate Release 15 March, 2007 SkyePharma PLC Co-Promotion Agreement for Zileuton CR LONDON, UK, ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com Critical Therapeutics Files Controlled Release Formulation of Zileuton... - Aug 1, 2006 The new formulation only needs to be taken twice a day whereas Zyflo(R), the currently marketed version of zileuton, has the drawback of requiring dosing ... Free with registration - PR Newswire - AccessMyLibrary.com Critical Therapeutics Completes Phase II Clinical Trial for Zileuton ... - Jun 2, 2008 Zileuton injection, at both dose levels, was well tolerated in all 36 patients and ... Patients at each of the two zileuton injection dose levels showed a ... RedOrbit Critical Therapeutics Initiates Phase II Clinical Trial for Zileuton... - Oct 3, 2007 ..."We believe zileuton injection represents a significant therapeutic opportunity for ... "By delivering zileuton directly to the bloodstream, the injectable ... Free with registration - Business Wire - AccessMyLibrary.com zileuton Critical Therapeutics clinical data (phase II) (acne).(antiac... - Jul 25, 2005 Critical Therapeutics announced results from a US phase II trial of zileuton tablets (ZYFLO FILMTAB) in patients with moderate-to-severe inflammatory facial ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Critical Therapeutics to cut workforce by half - Oct 27, 2006 ...said today it is restructuring of its US sales force and research and development group to focus its resources on the commercialization of zileuton, ... Boston Globe Learn about Zileuton from Consumer Reports Health. - Jan 6, 2008 Zileuton is used to prevent difficulty breathing, chest tightness, wheezing, and coughing due to asthma. Zileuton is not used to treat an asthma attack ... consumerreports.org … Captisol(R) to Critical Therapeutics for Injectable Formulation of... - Jun 12, 2007 The injectable formulation of zileuton is being developed for use in emergency ... Including zileuton, these partners have a total of 24 licensed Captisol ... Genetic Engineering News - Genetic Engineering News (press release) Chief executive of Critical Therapeutics resigns - Jun 26, 2006 The company expects to submit a new drug application for the controlled release zileuton in August. Shares of Critical Therapeutics fell 9 cents, ... Boston Globe Zileuton Improves Lung Function in Moderate to Severe Asthma Patients:... - Nov 4, 2005 By Ed Susman. MONTREAL, CANADA -- November 4, 2005 - Patients with moderate to severe asthma can improve aspects of pulmonary function with the ... DG News … Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets... - Sep 27, 2007 ZYFLO CR(TM) and ZYFLO(R) (zileuton tablets) are the only FDA-approved leukotriene synthesis inhibitors for the prophylaxis and chronic treatment of asthma ... Free with registration - PR Newswire - AccessMyLibrary.com How to take Zileuton from Consumer Reports Health. - Jan 6, 2008 ...tell your doctor and pharmacist if you are allergic to zileuton or any other medications. tell your doctor and pharmacist what prescription and ... consumerreports.org Zileuton Add-On Controls Severe Asthma as Well as Doubled Steroid … - Nov 7, 2005 By Crystal Phend. ANAHEIM, CA -- November 7, 2005 -- Uncontrolled moderate to severe asthma is typically treated by increasing the dose of anti-inflammatory ... DG News … on Target to Submit NDA for Zileuton Controlled-Release Tablets in... - May 2, 2006 The pharmacokinetic studies compare the bioavailability of zileuton CR ... Critical Therapeutics licensed zileuton CR and ZYFLO from a third party in late ... Genetic Engineering News - Genetic Engineering News (press release) … Announces Enrollment in Phase III Trial of Zileuton in Patients... - Oct 15, 2007 Patients will be randomized to receive either oral placebo or zileuton (600 mg ... ZYFLO CRTM (zileuton) extended-release tablets and ZYFLO are the only ... RedOrbit … Results of Phase I/II Trial of Intravenous Formulation of Zileuton. - Aug 23, 2006 Zileuton IV Well Tolerated at All Dose Levels and Positive Impact on Lung ... Patients in each of the four zileuton IV cohorts showed a greater mean ... Free with registration - Business Wire - AccessMyLibrary.com Critical Therapeutics begins news studies of zileuton. - Dec 20, 2005 SAN FRANCISCO (MarketWatch) -- Critical Therapeutics Inc. said after the closing bell on Tuesday it has initiated two new pharmacokinetic studies of ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com … Completes Phase I Clinical Trial of the R(+) Isomer of Zileuton - Apr 8, 2008 Twelve subjects each received two dose levels of the R(+) isomer of zileuton (100 and 300 mg) in a randomized, crossover design. ... Lifescience-online … Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets... - Sep 28, 2007 ZYFLO CR(TM) and ZYFLO(R) (zileuton tablets) are the only FDA-approved leukotriene synthesis inhibitors for the prophylaxis and chronic treatment of asthma ... Medical News Today - Medical News Today (press release) … Completes Clinical Trial of Intravenous Zileuton in Patients with... - Jul 25, 2006 The Company is developing zileuton IV initially for use in patients who suffer ... The Phase I/II clinical trial of zileuton IV is designed to evaluate the ... Free with registration - Business Wire - AccessMyLibrary.com … announces results from phase II study of zileuton in acne patients - Aug 9, 2005 2005 AUG 9 - (NewsRx.com) -- Critical Therapeutics, Inc., (CRTX) announced that the company's phase II study of ZYFLO Filmtab (zileuton tablets) in patients ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Critical Therapeutics' Zileuton Provides Additional Asthma Control... - Jun 26, 2007 Critical Therapeutics, Inc. (Nasdaq: CRTX), a biopharmaceutical company focused on the development and commercialization of products for respiratory, ... RedOrbit Press Release: Critical Therapeutics Inc. Review in Progress. - M2 … - Apr 9, 2008 Twelve subjects each received two dose levels of the R(+) isomer of zileuton (100 and 300 mg) in a randomized, crossover design. ... Pay-Per-View - M2 Presswire - HighBeam Research Critical Therapeutics Files Controlled Release Formulation Of Zileuton... - Aug 2, 2006 SkyePharma PLC (Nasdaq: SKYE; LSE: SKP) announces that its partner Critical Therapeutics Inc ("CTI", Nasdaq: CRTX) has submitted a New Drug Application to ... Medical News Today - Medical News Today (press release) Q4 2006 Critical Therapeutics, Inc. Earnings Conference Call - Final. - Feb 8, 2007 First is to obtain approval of our NDA for zileuton CR. Second is to optimize the launch of zileuton CR by supplementing our commercial resources with those ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Critical Therapeutics Announces FDA Approval of ZYFLO(R) for the … - Sep 28, 2005 ZYFLO, which contains the active ingredient zileuton, blocks the formation of leukotrienes ... Zileuton is an orally active inhibitor of 5-lipoxygenase, ... RedOrbit Skyepharma PLC - NDA for Zileuton CR. - Oct 24, 2006 RNS Number:9145K Skyepharma PLC 24 October 2006 For Immediate Release 24 October, 2006 SkyePharma PLC FDA accepts New Drug Application for zileuton CR ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com Study of oral zileuton in the treatment of moderate to severe facial... - May 1, 2005 This study is currently recruiting patients. Sponsored by Critical Therapeutics. Tissue inflammation is a major component of the acne disease process. ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com Controlled-release zileuton in pipeline for asthma.(Pulmonary... - Jan 15, 2007 SALT LAKE CITY -- A controlled-release formulation of the oral 5-lipoxygenase inhibitor zileuton proved safe and effective in asthma patients in a pivotal ... Free with registration - Family Practice News - AccessMyLibrary.com Controlled-Release Zileuton Tablets Shows Safety Profile Similar to … - Oct 27, 2006 By Ed Susman. SALT LAKE CITY, UT -- October 27, 2006 -- The investigative controlled-release (CR) oral agent zileuton appear to have a similar safety ... DG News Zileuton (Systemic).(Drug overview) - Aug 1, 2006 Zileuton (zye-LOO-ton) is used by patients with mild to moderate chronic asthma to decrease the symptoms of asthma and the number of acute asthma attacks. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Business & Finance; ZYFLO maker updates year, reports losses - Apr 1, 2005 In addition, we are seeking to broaden our zileuton franchise beyond asthma through the development of new formulations targeting a range of disease ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Critical Therapeutics starts Phase I trial of zileuton - Oct 9, 2007 Critical Therapeutics has initiated a phase I clinical trial to assess the safety and tolerability of an oral single dose of the R(+) isomer of experimental ... Pharmafocus … Completes Dosing of First Patient in Clinical Trial of Intravenous... - Feb 15, 2006 As an oral drug, zileuton has been studied in clinical trials involving more ... "This trial is our first clinical step toward developing IV zileuton as an ... RedOrbit Critical Thera up on Rhodia asthma agreement - Feb 11, 2005 Rhodia has already produced quantities of Critical Therapeutics' zileuton at both its Annan and Dudley, UK sites. When zileuton manufacturing is ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones Critical Therapeutics' Co-Promotion Partner, DEY, LP, Launches US … - May 2, 2007 Zileuton CR has a Prescription Drug User Fee Act (PDUFA) date of May 31, 2007. ZYFLO is the FDA-approved immediate-release formulation of zileuton, ... Genetic Engineering News - Genetic Engineering News (press release) Critical Therapeutics initiates open-label study of Zyflo; study... - Mar 14, 2005 Critical Therapeutics Inc has initiated an open-label, Phase IIIb study of its investigational drug, Zyflo Filmtab (zileuton tablets), for patients with ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com Critical Therapeutics Reports Second Quarter 2006 Financial Results - Jun 30, 2006 ..."In preparation for the commercial launch of zileuton CR, ... It has submitted an NDA for zileuton CR to the FDA for the prevention and chronic treatment of ... businesswire.com Article: Controlled-release zileuton in pipeline for asthma.(Pulmonary... - Jan 15, 2007 Controlled-release zileuton in pipeline for asthma.(Pulmonary Medicine)(drug approvals)(Brief article)(Clinical report) ... find Family Practice News ... Pay-Per-View - Family Practice News - HighBeam Research Article: Zyflo tablets post big gains.(What's New)(Critical Therapeuti... - Mar 3, 2008 Critical Therapeutics' Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release . ... 2007, average weekly prescriptions of ZYFLO CR and ZYFLO[R] (zileuton ... Pay-Per-View - Chain Drug Review - HighBeam Research Q1 2005 Critical Therapeutics Inc. Earnings Conference Call - Final. - May 10, 2005 At that meeting, the FDA stated that bioavailability trials for zileuton CR should be conducted in volunteers in a fasted state. Also during that meeting, ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com … on target to submit NDA for Zileuton controlled-release tablets in... - Jun 2, 2006 ..."The introduction of the CR formulation of zileuton would allow us to offer ... The pharmacokinetic studies compare the bioavailability of zileuton CR ... Pay-Per-View - Drug Week - Factiva, from Dow Jones … : FDA Approves ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for... - May 31, 2007 FDA Approves ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for Critical Therapeutics, DEY Marketing Partner for Chronic Treatment of Asthma. from PR ... Pay-Per-View - PR Newswire - HighBeam Research … Therapeutics submits NDA for controlled-release formulation of... - Aug 28, 2006 Zileuton CR is an investigational drug for the prevention and chronic treatment of asthma in adults and children 12 years of age and older. ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones … Therapeutics submits NDA for controlled-release formulation of... - Sep 2, 2006 Zileuton CR is an investigational drug for the prevention and chronic treatment of asthma in adults and children 12 years of age and older. ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones … Therapeutics submits NDA for controlled-release formulation of... - Aug 29, 2006 Zileuton CR is an investigational drug for the prevention and chronic treatment of asthma in adults and children 12 years of age and older. ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Generic name: Zileuton - Dec 1, 2005 Zyflo tablets prevent and relieve the symptoms of chronic asthma. The drug works by relaxing the muscles in the walls of your airways, allowing them to open ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com ZILEUTON (Oral route) - zye-LOO-ton.(Drug overview) - May 1, 2007 Zileuton is used by patients with mild to moderate chronic asthma to decrease the symptoms of asthma and the number of acute asthma attacks. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Critical Therapeutics Announces Publication of Results From Two... - Sep 13, 2007 The results of the trial indicate that the nature of zileuton-associated liver ... After three months, the risk of elevated ALT levels in zileuton-treated ... RedOrbit Q1 2006 Critical Therapeutics, Inc. Earnings Conference Call - Final. - May 4, 2006 Approval of our zileuton CR would offer patients a more convenient dosing ... We have ongoing Phase I/II study of intravenous zileuton and enrollment is ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Critical Therapeutics' ZYFLO(R) Receives Distinct Classification... - May 25, 2006 ZYFLO, the immediate release tablet formulation of zileuton, blocks the ... The Company owns worldwide rights to the asthma drug ZYFLO(R) (zileuton tablets) ... Free with registration - Business Wire - AccessMyLibrary.com Critical Therapeutics Achieves Collaboration Milestone in HMGB1 … - Dec 8, 2005 The Company owns worldwide rights to ZYFLO(R) (zileuton tablets), as well as other formulations of zileuton. ZYFLO is the only 5-lipoxygenase inhibitor ... biotech-intelligence.com Use of injectable zileuton may not be a panacea for asthma - Oct 8, 2007 Several questions arise about injectable Zileuton. Inhaled steroids still remain the mainstay of theray for asthma. Will patients accept the use of an ... Gerson Lehrman Group … ' Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for ... - May 31, 2007 Critical Therapeutics' Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for Asthma Approved by FDA. from M2 Presswire. Pay-Per-View - M2 Presswire - HighBeam Research SkyePharma and CTI submit reformulated zileuton to FDA.(Critical … - Aug 14, 2006 UK-based drugmaker SkyePharma says that its US partner Critical Therapeutics has completed the submission of a New Drug Application to the US Food and Drug ... Free with registration - Pharma Marketletter - AccessMyLibrary.com drug delivery system, GEOMATRIX controlled-release zileuton, Critical... - Nov 6, 2006 The controlled-release formulation of zileuton incorporates SkyePharma's GEOMATRIX oral delivery technology. Critical Therapeutics acquired rights from ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones … Controlled Release Formulation of Zileuton. - PR Newswire |... - Aug 1, 2006 Critical Therapeutics Files Controlled Release Formulation of Zileuton. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Critical Therapeutics' Zyflo reduces need for rescue medication and … - Nov 2, 2005 For example, only 5.9% of the severe asthma patients in the zileuton group required oral corticosteroids, compared with 25.5% of severe asthma patients on ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Critical Therapeutics Announces Schedule of Upcoming Investor … - Nov 2, 2006 The Company owns worldwide rights to ZYFLO(R) (zileuton tablets), which is marketed ... Critical Therapeutics is working to expand its zileuton franchise by ... Genetic Engineering News - Genetic Engineering News (press release) CyDex licenses Captisol for injectable zileuton. - Jun 18, 2007 CyDex licenses Captisol for injectable zileuton. Kansas, USA-based CyDex has signed a license and supply agreement granting exclusive worldwide rights to ... $9.94 - Pharma Marketletter - Alacra Store Critical Therapeutics Reports Preliminary Operating Results for the... - Jan 9, 2007 Zileuton CR utilizes SkyePharma's Geomatrix® technology. ... ZYFLO® (zileuton tablets) is indicated for the prevention and chronic treatment of asthma in ... RedOrbit FDA approves Zyflo for asthma. - Oct 10, 2005 ...based Critical Therapeutics announced that the FDA has approved its application to manufacture and market Zyflo (zileuton tablets). ... $9.94 - Drug Topics - Alacra Store Critical Therapeutics Reports Third Quarter 2006 Financial Results - Nov 9, 2006 Pending FDA approval, the Company is targeting the launch of zileuton CR for the ... In this trial, zileuton IV was well tolerated at all dosage levels and ... Genetic Engineering News - Genetic Engineering News (press release) Critical Therapeutics to Report Third Quarter 2007 Financial Results... - Nov 8, 2007 ...treatment of asthma in patients 12 years of age and older: twice-daily ZYFLO CR™ (zileuton) extended-release tablets and ZYFLO® (zileuton tablets). ... businesswire.com Critical Therapeutics Reports Fourth Quarter and Full Year 2004... - Feb 17, 2005 In addition, we are seeking to broaden our zileuton franchise beyond asthma through the development of new formulations targeting a range of disease ... $4.95 - Business Wire - ECNext Critical Therapeutics Announces Schedule of Upcoming Investor … - Apr 20, 2006 The Company owns worldwide rights to ZYFLO(R) (zileuton tablets), as well as other formulations of zileuton. ZYFLO is the only 5-lipoxygenase inhibitor ... Free with registration - Business Wire - AccessMyLibrary.com CT signs zileuton CR promotion deal with DEY. - Mar 19, 2007 CT signs zileuton CR promotion deal with DEY. The UK's SkyePharma says that its partner for asthma drug zileuton CR, Critical Therapeutics, has entered into ... $9.94 - Pharma Marketletter - Alacra Store SkyePharma's zileuton partner Critical Thera in co-promotion accord. - Mar 26, 2007 SkyePharma's zileuton partner Critical Thera in co-promotion accord. UK-based drug developer SkyePharma says that US firm Critical Therapeutics, ... $9.94 - Pharma Marketletter - Alacra Store Extended-release asthma tablets.(Products) - Nov 1, 2007 The extended-release version of Zyflo (zileuton) tablets, Zyflo CR, is now for sale in the United States as a twice-daily medication for the prevention and ... $4.95 - Pediatric News - ECNext Critical Therapeutics' Zyflo: good combo data.(Brief Article) - Nov 14, 2005 In addition, severe persistent patients taking zileuton plus BDP showed a greater reduction in their use of rescue medication. ... Free with registration - Pharma Marketletter - AccessMyLibrary.com CT signs zileuton CR promotion deal with DEY.(Critical Therapeutics... - Mar 19, 2007 The UK's SkyePharma says that its partner for asthma drug zileuton CR, Critical Therapeutics, has entered into a co-promotion agreement with DEY, ... $4.95 - Pharma Marketletter - ECNext Press Release: Progressive Following on Critical Therapeutics Inc. -... - Apr 9, 2008 R(+) zileuton combined in equal proportion with its mirror image isomer, S(-) zileuton, comprise racemic zileuton, which is the pharmaceutical ingredient in ... Pay-Per-View - M2 Presswire - HighBeam Research Critical Therapeutics Reports Financial Results for the Quarter Ended... - May 8, 2007 During the first quarter of 2007, sales of ZYFLO[R] (zileuton tablets) totaled ... Pending regulatory approval by the FDA of zileuton CR, a combined sales ... Free with registration - Business Wire - AccessMyLibrary.com Critical Therapeutics Reports Financial Results for the Quarter Ended... - Mar 31, 2007 During the first quarter of 2007, sales of ZYFLO® (zileuton tablets) ... Pending regulatory approval by the FDA of zileuton CR, a combined sales force of ... RedOrbit Critical Therapeutics sells shares to raise $54.5 million - Jun 8, 2005 The net proceeds from this private placement will be used to launch Critical's investigational asthma drug Zyflo Filmtab (zileuton tablets) pending ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones … Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release T - Sep 27, 2007 Article: FDA Approves ZYFLO CR(TM) (Zileuton) ... PR Newswire; May 31, ... About ZYFLO CR and ZYFLO ZYFLO CR(TM) (zileuton) extended-release ... of age and ... Pay-Per-View - PR Newswire - HighBeam Research Mastocytosis; Open-label study of ZYFLO begins - Apr 11, 2005 Critical Therapeutics licensed exclusive worldwide rights to ZYFLO and other forms of zileuton from Abbott Laboratories and is in the process of ... Pay-Per-View - Respiratory Therapeutics Week - Factiva, from Dow Jones Critical Therapeutics Announces Results of CTI-01 Phase II Trial. - Sep 15, 2006 The Company owns worldwide rights to the asthma drug ZYFLO(R) (zileuton tablets), as well as other formulations of zileuton. ... $4.95 - Business Wire - ECNext Critical Therapeutics Reports Second Quarter 2006 Financial Results. - Aug 3, 2006 ..."In preparation for the commercial launch of zileuton CR, pending regulatory ... --It has submitted an NDA for zileuton CR to the FDA for the prevention and ... $4.95 - Business Wire - ECNext Critical Therapeutics Announces Research on ZYFLO(R) Presented at … - Mar 6, 2006 Lung function measurements were obtained from patients on 600 mg zileuton four times per day (the prescribed dose) compared with placebo. ... Free with registration - Business Wire - AccessMyLibrary.com Speak with other shareholders about: (OTCBB: TCNH), (NASD: CRTX), ( … - May 15, 2007 The Company owns worldwide rights to ZYFLO (zileuton tablets), which is marketed in ... Critical Therapeutics is working to expand its zileuton franchise by ... Free with registration - M2 Presswire - AccessMyLibrary.com Press Release: Critical Therapeutics ZYFLO CR Extended-Release … - May 31, 2007 Critical Therapeutics' Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release . ... ZYFLO CR and ZYFLO(R) (zileuton tablets) are ... ... Pay-Per-View - M2 Presswire - HighBeam Research The effects of a 5-lipoxygenase inhibitor on acute mountain sickness... - Feb 1, 2005 Zileuton is an inhibitor of the enzyme 5-lipoxygenase that catalyzes ... One subject in the zileuton group and three subjects in the placebo group met Lake ... Pay-Per-View - Chest - Factiva, from Dow Jones Article: Extended-release asthma tablets.(Products) - Pediatric News... - Nov 1, 2007 Products) ... find Pediatric News articles. The extended-release version of Zyflo (zileuton) tablets, Zyflo CR, is now for sale in the United States as a... Pay-Per-View - Pediatric News - HighBeam Research Critical Therapeutics to Present Data on ZYFLO(R) at the 2006 … - May 23, 2006 Mice in the study were treated with montelukast, zileuton and a positive control ... While increased airway eosinophils were reduced by both drugs, zileuton ... Genetic Engineering News - Genetic Engineering News (press release) Business & Finance; Critical Therapeutics reports $14.4 million... - Sep 5, 2006 ..."In preparation for the commercial launch of zileuton CR, ... It has submitted an NDA for zileuton CR to the FDA for the prevention and chronic treatment of ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Article: Asthma drug.(RXs)(Brief article) - Chain Drug Review |... - Jun 25, 2007 Critical Therapeutics' Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release . ... 2007, average weekly prescriptions of ZYFLO CR and ZYFLO[R] (zileuton ... Pay-Per-View - Chain Drug Review - HighBeam Research Article: TAKING STOCK ; YOUR AT-A-GLANCE GUIDE - Evening … - Jun 1, 2007 Critical Therapeutics' Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release . ... 2007, average weekly prescriptions of ZYFLO CR and ZYFLO[R] (zileuton ... Pay-Per-View - Evening Standard - London - HighBeam Research Press Release: Critical Therapeutics Inc Announces Data Publication. ... - Jun 13, 2007 ZYFLO CR and the immediate release formulation of zileuton, ZYFLO (zileuton ... The study, titled "The Safety and Efficacy of Zileuton Controlled-Release ... Pay-Per-View - M2 Presswire - HighBeam Research Alerts: Turning Pennies into dollars: (OTCBB: TCNH), (NASD: CRTX), ( … - May 16, 2007 The Company owns worldwide rights to ZYFLO (zileuton tablets), which is marketed in ... Critical Therapeutics is working to expand its zileuton franchise by ... $4.95 - M2 Presswire - ECNext Two Studies Support Efficacy of Critical Therapeutics' ZYFLO in... - May 23, 2005 He concluded that zileuton 600 mg administered four times per day (the ... In the zileuton group, rapid and sustained improvement in lung function was ... RedOrbit Business & Finance; Critical Therapeutics reports net loss of $16.7... - Jun 7, 2006 These reductions should provide additional capital to support the anticipated 2007 launch of the controlled-release (CR) formulation of zileuton. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Critical Therapeutics Licenses Rights for Vagus Nerve Stimulation... - Jan 30, 2007 The Company owns worldwide rights to ZYFLO[R] (zileuton tablets), which is marketed ... Critical Therapeutics is working to expand its zileuton franchise by ... Free with registration - Business Wire - AccessMyLibrary.com ASVP, CRTX, TCNH, UGTH, CPNE "Red Hot Penny Stock Alert". - May 14, 2007 Zileuton CR has a Prescription Drug User Fee Act (PDUFA) date of May 31, 2007. ZYFLO is the FDA-approved immediate-release formulation of zileuton, ... Free with registration - M2 Presswire - AccessMyLibrary.com CRLD, CRTX, NAWL, KDKN - OTCStockExchange.com Stock Alert. - May 14, 2007 Zileuton CR has a Prescription Drug User Fee Act (PDUFA) date of May 31, 2007. ZYFLO is the FDA-approved immediate-release formulation of zileuton, ... Free with registration - M2 Presswire - AccessMyLibrary.com Brand Names/Synonyms: Zileuton is also known by the following brand names and/or synonymsAbbott 64077; Leutrol; ZILEUTON; Zileuton; Zileuton [Usan:Ban:Inn]; Zileutonum [Inn-Latin]; Zyflo; [Usan:Ban:Inn] Drug Category: Zileuton is categorized under the following by the FDA: Anti-ashtmatic; Anti-inflammatory Agents; Leukotriene Antagonists; Lipoxygenase Inhibitors Dosage Forms: TABLET Absorption: Zileuton is rapidly absorbed upon oral administration with a mean time to peak plasma concentration (Tmax ) of 1.7 hours and a mean peak level (Cmax) of 4.98 µg/mL Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 1-(1-benzothiophen-2-ylethyl)-1-hydroxy-urea |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |